- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT04402320
Non Invasive and Invasive Ventilation Post Extubation
25 mai 2020 mis à jour par: King Abdul Aziz Specialist Hospital
Comparative Study Between Usage of NIV Versus MV for One Hour After Fulfillment of Weaning Criteria From Ventilation on Re-intubation in Post-traumatic ARDS
Patients and methods: It is a prospective double blind study done on total 300 patients.
Admitted with respiratory failure ARDS due to severe lung contusion.
All of them selected to be ventilated for one week or more.
Patients were randomly allocated in one of three groups each group contain 100 patients.
Group A considered control extubated and follow our routine protocol, patients of group B reconnected to mechanical ventilation before extubation for one hour.
patients of Group C extubated and immediately connected to NIV with BIPAP mode for 1 hour every 12 hours for 24 hours.
Results: There was significant reduction in the number of patients had deterioration in conscious level in all the duration of the study in patients of both groups B and C compared to group A. Also significant reduction in the number of patients had deterioration in clinical parameters of respiration in all the duration of the study in patients of both groups B and C compared to group A as regards high respiratory rate, desaturation and development of hyperdynamic circulation (tachycardia and hypertension).
significant reduction in the number of patients had multiple quadrant parenchymatous infiltration in all the duration of the study in patients of both groups B and C compared to group A. significant reduction in the number of patients had marked limitation to FEV1, FVC and MVV in all the duration of the study in patients of both groups B and C compared to group A. Conclusion: Use of either NIV every 12 hours for 24 hours or MV for one hour after fulfillment of weaning criteria reduces reintubation and post-extubation respiratory failure and decrease the ICU stay in critically ill patients with resolving ARDS due to severe lung trauma.
Aperçu de l'étude
Statut
Complété
Les conditions
Intervention / Traitement
Description détaillée
It is a prospective double-blind study done on total 300 patients.
Admitted to King Abdulaziz specialist hospital in Taif, KSA.
Between April 2019 and April 2020 with respiratory failure ARDS due to severe lung contusion with these criteria: hypoxic index less than 200, bilateral parenchymatous lung infiltrate, no any acute cardiac insult, failed to maintain SPO2 more than 90% with Non-Invasive Ventilation (NIV) or need of continuous NIV to maintain the previous saturation.
This selected ARDS was due to lung contusion which diagnosed by Computerized tomography of the chest following chest trauma.
All of them selected to be ventilated for one week or more and only those who showed full criteria of weaning from the ventilator enrolled in our study.
Our criteria of weaning include fully conscious patients, hemodynamically stable without any inotropic support, hypoxic index(PAO2/FIO2) more than 200 calculated from the arterial blood gases (ABG), bicarbonate level in arterial blood more than 20 mmol/l, hemoglobin level more than 10 gm%, chest X ray less than one quadrant parenchymatous infiltration in each lung on Murray score of chest Xray, rapid shallow breathing index <105.
Patients were randomly allocated in one of three groups each group contain 100 patients.
Randomization sequence was created using Excel 2007 (Microsoft, Redmond, WA, USA) with a 1:1 allocation using random block sizes of 2 and 4 by an independent doctor.
In this way, sequence generation and type of randomization can be expressed at the same time.
Patients of group A extubated and followed our routine protocol of management post extubation which include Nebulization with Ventolin and epinephrine racemic every 8 hours for 48 hours, chest physical therapy (CPT) every 6 hours for 48 hours include clapping percussion with mechanical vibration and suction plus huffing or coughing and postural drainage if there was atelectasis seen by our routine chest X ray.
Patients of group B reconnected to mechanical ventilation before extubation for one hour with sedation with midazolam 3-5 milligram/hour intravenous infusion to achieve score 0 or -1on Richmond Agitation - Sedation Scale (RASS).
20 minutes before the end of this hour midazolam infusion discontinued and patients awaked.
Patient put on mechanical ventilation (MV) with the following parameters, FIO2 40%, pressure SIMV mode, PEEP 8 cmH2O, Pressure support 15 cmH2O, Respiratory rate 14/min, Peak inspiratory pressure (PIP) of 35 cmH2O.
Then patients extubated and followed our previous protocol without the use of NIV.
Type d'étude
Observationnel
Inscription (Réel)
300
Contacts et emplacements
Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.
Lieux d'étude
-
-
-
Ta'if, Arabie Saoudite, 21944
- King abd el Aziz specialist hospital
-
-
Critères de participation
Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.
Critère d'éligibilité
Âges éligibles pour étudier
18 ans à 65 ans (Adulte, Adulte plus âgé)
Accepte les volontaires sains
Non
Sexes éligibles pour l'étude
Tout
Méthode d'échantillonnage
Échantillon de probabilité
Population étudiée
on total 300 patients.
Admitted to King Abdulaziz specialist hospital in Taif, KSA.
Between April 2019 and April 2020 with respiratory failure ARDS due to severe lung contusion with these criteria: hypoxic index less than 200, bilateral parenchymatous lung infiltrate, no any acute cardiac insult, failed to maintain SPO2 more than 90% with Non-Invasive Ventilation (NIV) or need of continuous NIV to maintain the previous saturation.
This selected ARDS was due to lung contusion which diagnosed by Computerized tomography of the chest following chest trauma.
All of them selected to be ventilated for one week or more and only those who showed full criteria of weaning from the ventilator enrolled in our study
La description
Inclusion Criteria:
- respiratory failure ARDS due to severe lung contusion
Exclusion Criteria:
- post arrest, deeply comatosed patients and children below 18 years
Plan d'étude
Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.
Comment l'étude est-elle conçue ?
Détails de conception
- Modèles d'observation: Cohorte
- Perspectives temporelles: Éventuel
Cohortes et interventions
Groupe / Cohorte |
Intervention / Traitement |
|---|---|
|
Control group
extubated and weaning from the ventilator and followed our routine protocol of management post extubation without mechanical ventilation or BIPAP machine
|
reconnected to mechanical ventilation before extubation for one hour with sedation with midazolam 3-5 milligram/hour intravenous infusion to achieve score 0 or -1on Richmond Agitation - Sedation Scale (RASS).
20 minutes before the end of this hour midazolam infusion discontinued and patients awaked.
Patient put on mechanical ventilation (MV) with the following parameters, FIO2 40%, pressure SIMV mode, PEEP 8 cmH2O, Pressure support 15 cmH2O, Respiratory rate 14/min, Peak inspiratory pressure (PIP) of 35 cmH2O.
Then patients extubated and followed our previous protocol without the use
Autres noms:
reconnected to mechanical ventilation before extubation for one hour with sedation
|
|
Invasive ventilation group
reconnected to mechanical ventilator before extubation for one hour with sedation with midazolam 3-5 milligram/hour intravenous infusion to achieve score 0 or -1on Richmond Agitation - Sedation Scale (RASS).
20 minutes before the end of this hour midazolam infusion discontinued and patients awaked.
Patient put on mechanical ventilation (MV) with the following parameters, FIO2 40%, pressure SIMV mode, PEEP 8 cmH2O, Pressure support 15 cmH2O, Respiratory rate 14/min, Peak inspiratory pressure (PIP) of 35 cmH2O.
Then patients extubated and followed our previous protocol without the use of NIV.
|
reconnected to mechanical ventilation before extubation for one hour with sedation with midazolam 3-5 milligram/hour intravenous infusion to achieve score 0 or -1on Richmond Agitation - Sedation Scale (RASS).
20 minutes before the end of this hour midazolam infusion discontinued and patients awaked.
Patient put on mechanical ventilation (MV) with the following parameters, FIO2 40%, pressure SIMV mode, PEEP 8 cmH2O, Pressure support 15 cmH2O, Respiratory rate 14/min, Peak inspiratory pressure (PIP) of 35 cmH2O.
Then patients extubated and followed our previous protocol without the use
Autres noms:
reconnected to mechanical ventilation before extubation for one hour with sedation
|
|
non invasive ventilation group
following the same previous protocol done after extubation with immediate connection to NIV with BIPAP mode for 1 hour and repeated every 12hours for 48 hours, BIPAP adjusted in our study by FIO2 40%, PEEP 8 cmH2O, Pressure support of 15 cmH2O.
|
reconnected to mechanical ventilation before extubation for one hour with sedation with midazolam 3-5 milligram/hour intravenous infusion to achieve score 0 or -1on Richmond Agitation - Sedation Scale (RASS).
20 minutes before the end of this hour midazolam infusion discontinued and patients awaked.
Patient put on mechanical ventilation (MV) with the following parameters, FIO2 40%, pressure SIMV mode, PEEP 8 cmH2O, Pressure support 15 cmH2O, Respiratory rate 14/min, Peak inspiratory pressure (PIP) of 35 cmH2O.
Then patients extubated and followed our previous protocol without the use
Autres noms:
reconnected to mechanical ventilation before extubation for one hour with sedation
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
number of patients re-intubated within 48 hours and shorten the duration of ICU stay
Délai: 48 hours
|
monitoring hemodynamics, oxygenation, and conscious level in the studied duration
|
48 hours
|
Collaborateurs et enquêteurs
C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.
Parrainer
Dates d'enregistrement des études
Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.
Dates principales de l'étude
Début de l'étude (Réel)
10 avril 2019
Achèvement primaire (Réel)
2 avril 2020
Achèvement de l'étude (Réel)
20 avril 2020
Dates d'inscription aux études
Première soumission
20 mai 2020
Première soumission répondant aux critères de contrôle qualité
20 mai 2020
Première publication (Réel)
26 mai 2020
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
27 mai 2020
Dernière mise à jour soumise répondant aux critères de contrôle qualité
25 mai 2020
Dernière vérification
1 mai 2020
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
- Maladies des voies respiratoires
- Troubles respiratoires
- Signes et symptômes respiratoires
- Insuffisance respiratoire
- Hypoxie
- Effets physiologiques des médicaments
- Agents neurotransmetteurs
- Mécanismes moléculaires de l'action pharmacologique
- Dépresseurs du système nerveux central
- Anesthésiques intraveineux
- Anesthésiques, général
- Anesthésiques
- Agents tranquillisants
- Médicaments psychotropes
- Hypnotiques et sédatifs
- Adjuvants, Anesthésie
- Agents anti-anxiété
- Modulateurs GABA
- Agents GABA
- Midazolam
Autres numéros d'identification d'étude
- ICU-19-20
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Non
Description du régime IPD
see if both iv or niv after fullfilling the criteria of extubation in ARDS patients can prevent reintubation
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Oui
Étudie un produit d'appareil réglementé par la FDA américaine
Oui
produit fabriqué et exporté des États-Unis.
Non
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .